home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410n.zip
/
M94A2602.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
44 lines
Document 2602
DOCN M94A2602
TI Comparison of cervical cytology with colposcopic biopsies in U.S.
HIV-infected women.
DT 9412
AU Gagnon S; Cohn J; Spence M; Harrison D; Brinson C; Stein A; Hellinger J;
UKSM-W, Wichita.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):267 (abstract no. PB0499). Unique
Identifier : AIDSLINE ICA10/94369973
AB OBJECTIVE: To compare Papanicolaou (PAP) smears to colposcopic
evaluations in diagnosing precursors of cervical cancer in a broad cross
section of immunosuppressed HIV-infected women. METHODS: HIV-infected
women in 6 US cities with a CD4 count < or = 500, without prior cervical
cancer or cervical dysplasia in the past two years were enrolled by
their primary care providers into a cross sectional study. CD4 cell
counts, PAP smears and colposcopic evaluations with mandatory biopsies
were obtained on all women. RESULTS: Preliminary data are available on
72 of 126 women. Median CD4 cell count was 272 (R, 10-578). On biopsy
24% of women had cervical intraepithelial neoplasia (CIN), 6% had CIN II
or III, and no women had cervical cancer. A suspicious PAP smear
(containing either atypical cells, evidence of papilloma virus infection
or squamous epithelial lesion) had a sensitivity for all CIN of 0.59,
specificity of 0.78, a negative predictive value of 0.86 and a false
negative rate of 0.41, but a sensitivity for CIN II or CIN III of 1.00,
specificity of 0.73, a negative predictive value of 1.00 and a false
negative rate of 0.00. CONCLUSION: In this group of HIV-infected,
immunosuppressed women with a prevalence of CIN of 24%, a single PAP
smear had more than a 40% false negative rate for all CIN but no cases
of CIN II or III were missed. If progression of cervical disease is
rapid in these women, a PAP smear may not been an adequate screen.
Strategies of performing repeated PAP smears and comparing results with
colposcopy over time will measure the rate of cervical disease
progression and determine the most appropriate standard of gynecologic
care for these women.
DE Cell Transformation, Neoplastic/PATHOLOGY Cervical Intraepithelial
Neoplasia/PATHOLOGY Cervix Neoplasms/*PATHOLOGY Cervix Uteri/PATHOLOGY
*Colposcopy Comparative Study Cross-Sectional Studies Female Human
HIV Infections/*PATHOLOGY Neoplasm Staging Precancerous
Conditions/*PATHOLOGY Risk Factors Vaginal Smears MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).